Fight Cat Allergies With Newest Asthma Drug?
Subcutaneous immunotherapy treatment (SCIT) for reducing cat allergy symptoms appeared to be more effective and longer lasting with the help of tezepelumab (Tezspire), a monoclonal antibody recently approved for severe asthma, results from a phase I/II trial suggested. While the randomized CATNIP trial failed to meet its primary endpoint — a difference in total nasal […]